Evidence map›Paper›PMID 8294884›Full record

ArticleThe Journal of experimental medicine1994

Distinct structural compartmentalization of the signal transducing functions of major histocompatibility complex class II (Ia) molecules.

P André, J C Cambier, T K Wade, T Raetz, W F Wade

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. The diverse functions of Src family kinases in macrophages.Frontiers in bioscience : a journal and virtual library · 2008
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis.Proceedings of the National Academy of Sciences of the United States of America · 1996
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

P AndréDepartment of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206.
J C Cambier
T K Wade
T Raetz
W F Wade
National Jewish Health · US

Funding

MOLECULAR BIOLOGY OF B CELL TOLERANCE AND ACTIVATIONR01AI020519 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CAMBIER, JOHN C. · 1985 to 2007
$2.3M
SIGNAL TRANSDUCTION IN B CELL ACTIVATIONR01AI021768 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C. · 1985 to 1995
–
B CHAIN OF IA--STRUCTURE AND FUNCTIONR29AI031160 · NIAID · UNIVERSITY OF NEBRASKA LINCOLN · PI WADE, WILLIAM FRANKLIN · 1991 to 1995
–
NIAID NIH HHS AI-20519NIAID NIH HHS AI-21768NIAID NIH HHS AI-31160
6 · The paper itself

Abstract

Class II major histocompatibility complex encoded proteins (MHC class II or Ia molecules) are principal plasma membrane proteins involved in activation of both B and T cells during antigen-driven immune responses. Recent data indicate that class II molecules are more than simply recognition elements that provide a ligand for the T cell antigen receptor. Changes in B cell physiology that follow class II binding are now recognized as being required not only for the induction of T cell activation, but also for B cell activation and proliferation. It is interesting to note that class II molecules appear to transduce signals via two distinct mechanisms depending upon the differentiative state of the B cell on which they are expressed. While one of these pathways, involving cAMP generation and protein kinase C localization in the cytoskeletal/nuclear compartment, is seen in resting B cells, the second is seen in primed B cells and involves tyrosine kinase activation, inositol lipid hydrolysis, and Ca2+ mobilization. Use of this pathway is correlated with ability of class II to transduce signals leading to B cell proliferation. To begin to address the molecular basis of this unique, activation-dependent, differential coupling of class II to signaling pathways, we conducted mutational analysis of class II structural requirements for signal transduction. Here we report that the cytoplasmic (Cy) domains of I-Ak class II molecules are not required for either receptor-mediated activation of protein tyrosine phosphorylation or Ca2+ mobilization. This is in contrast to the requirement of the Cy domain of beta chain of class II for the alternate signaling pathway and efficient antigen presentation to autoreactive T cell lines. Disparate distribution of functional motifs within the MHC class II molecules may reflect use of distinct receptor associated effector molecules to sustain different modes of signal transduction in various class II-expressing cells.

Indexed as

Signal TransductionAmino Acid SequenceAnimalsCalciumHistocompatibility Antigens Class IIHumansMiceMolecular Sequence DataProtein ConformationTransfectionTyrosineCalciumHistocompatibility Antigens Class IITyrosine

Identifiers

PMID8294884
PMCPMC2191390
OpenAlexW2112605756

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.